Royal Philips

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment businesses; Connected Care businesses; Personal Health businesses; and Other. The Diagnosis and Treatment businesses segment consists systems, smart devices, software and services, powered by AI-enabled informatics-that support precision diagnoses and minimally invasive procedures in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care businesses segment consists Hospital Patient Monitoring, Emergency Care, Sleep & Respiratory Care and Connected Care Informatics. The Personal Health businesses segment consists of Oral Healthcare, Personal Care,Mother and Child Care. The Other segment reports on the items Innovation & Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment; Connected Care; Personal Health; and Other. The Diagnosis and Treatment segment consists of systems, smart devices, software, and services, powered by AI-enabled solutions that support precision diagnoses and minimally invasive treatment in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care segment focuses on Hospital Patient Monitoring, Sleep and Respiratory Care, and Enterprise Informatics. The Personal Health segment represents Oral Healthcare business unit, Personal Care business unit, and Mother and Child Care business unit. The Other segment is involved on the Innovation and Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Sonic power meets intelligent care, with the new Philips Sonicare 9900 Prestige

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Royal Philips (NYSE: PHG) to BioTelemetry, Inc. (NasdaqGS: BEAT). Under the terms of the proposed transaction, shareholders of Royal Philips will receive only $72.00 in cash for each share of Royal Philips that they own. KSF is seeking to determine whether this consideration and the process that led to it are

ROYAL PHILIPS INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Royal Philips - PHG

Philips, BioIntelliSense and University of Colorado receive U.S. Department of Defense funding for early COVID-19 detection

HeartBeam

Philips (PHG) enters into a deal to acquire BioTelemetry, which drives the expansion of its cardiac care portfolio and fuels customer acquisition.

Philips (PHG) Expands Portfolio With BioTelemetry Acquisition

NEW YORK, Dec. 18, 2020 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by BioTelemetry, Inc. (NASDAQ: BEAT) and its board of directors concerning the proposed acquisition of the company by Royal Philips (NYSE: PHG). Stockholders will receive $72.00...

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of BioTelemetry, Inc.

BioTelemetry gained as much as 18% on Friday after news that the cardiac-diagnostics firm will be acquired by Dutch company Royal Philips for $2.8 billion. BioTelemetry is a Pennsylvania-based medical company that makes equipment that remotely diagnoses and monitors cardiac activity.

BioTelemetry soars 18% after Philips announces acquisition of cardiac-diagnostics company

Philips to become a global leader in patient care management solutions for the hospital and the home through the acquisition of BioTelemetry, Inc.

Philips and InSightec partner to expand access to MR-guided focused ultrasound for incisionless neurosurgery

Royal Philips (PHG) closed at $51.94 in the latest trading session, marking a +0.31% move from the prior day.

Royal Philips (PHG) Gains As Market Dips: What You Should Know

Adding green energy to the grid: Philips, HEINEKEN, Nouryon and Signify form first Pan-European consortium for future wind farm

American Well Corporation

CVS Health

Global X Telemedicine & Digital Health ETF

Teladoc

Expect telehealth stocks to continue trending upward even though Covid-19 is slowly but surely receding into the background. The post 5 Telehealth Stocks That Will Keep Growing Post-Quarantine appeared first on InvestorPlace.

5 Telehealth Stocks That Will Keep Growing Post-Quarantine

Royal Philips (PHG) closed at $51.61 in the latest trading session, marking a -1% move from the prior day.

Royal Philips (PHG) Stock Sinks As Market Gains: What You Should Know

Philips new DreamWear Silicone Pillows designed using 3D facial scan data to fit diverse populations

Philips again recognized for its commitment to action on climate change

Philips boosts digital pathology with enhanced informatics to advance precision diagnosis in oncology

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced its support for #BlanketChange, an advocacy campaign led by March of Dimes that calls on policymakers to improve maternal and infant health. Today, the U.S. is among the most dangerous developed nations for childbirth, a situation that has intensified with COVID-19. As of January 1, 2020, 120 rural healthcare facilities have closed, and a new March of Dimes report finds

Philips Partners With March of Dimes to Support #BlanketChange for Improved Maternal and Infant Health

Philips Ambient Experience helps Phoenix Children's Hospital deliver pediatric-centered cancer care

Philips highlights its expanding enterprise imaging informatics portfolio at RSNA 2020

Philips expands its healthcare customer services portfolio with the introduction of integrated Cybersecurity Services

Philips Patient Management Solution keeps patients safe and personalizes care during COVID-19 at leading U.S. medical centers

Philips debuts AI-enabled, automated Radiology Workflow Suite at RSNA 2020

Philips introduces industry-first vendor-neutral Radiology Operations Command Center at RSNA 2020

Leading pathology laboratories deploy tele-diagnostics with Philips during the COVID-19 pandemic

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the publication of the U.S. edition of its Future Health Index (FHI) 2020 report, the first global survey of its kind. Now in its fifth year, the Future Health Index 2020 report – ‘The age of opportunity: Empowering the next generation to transform healthcare' – reveals critical insights from healthcare professionals under the age of 40, a group that will comprise most

Next Generation American Healthcare Professionals Are Among Highest in Workplace Stress in New Global Report

Philips World COPD Day survey reveals care challenges, telehealth adoption, and increased global awareness surrounding respiratory health

News for Royal Philips Stock (PHG)